Pig Kidney Xenotransplant Successfully Bridges Patient to Human Kidney Transplant
Source Summary
Tim Andrews received a genetically edited pig kidney in January 2025 and subsequently received a human kidney transplant in January 2026. A new study published in The Lancet by Mass General Brigham documents Andrews' case and demonstrates how xenotransplantation can serve as a bridge therapy, allowing end-stage kidney disease patients to avoid dialysis while awaiting human organ availability.
Why it matters
This case demonstrates that xenotransplantation can provide a viable interim solution for end-stage kidney disease patients, potentially reducing dependence on dialysis and improving quality of life while awaiting human organ availability.
